arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2606.20143cs.CV

头颈肿瘤 (HECKTOR) 2025 挑战赛:多模态 PET/CT 中的分割、诊断与预后基准

HEad and neCK TumOR (HECKTOR) 2025: Benchmark of Segmentation, Diagnosis, and Prognosis in Multimodal PET/CT

Mohamed bin Zayed University of Artificial Intelligence (MBZUAI)(穆罕默德·本·扎耶德人工智能大学);Amsterdam UMC(阿姆斯特丹大学医学中心);The Netherlands Cancer Institute(荷兰癌症研究所);Radboud University Medical Centre(拉德堡德大学医学中心);University College London(伦敦大学学院);Imperial College London(帝国理工学院);Shenzhen Technology University(深圳技术大学);Shenzhen University(深圳大学);Newland Digital Technology(新大陆数字技术);The University of Sydney(悉尼大学);Shanghai Jiao Tong University(上海交通大学);University Hospital, Nantes(南特大学医院);Nantes Université, Centrale Nantes, CNRS, LS2N(南特大学、南特中央理工学院、法国国家科学研究中心、LS2N实验室);Hangzhou Dianzi University(杭州电子科技大学);Tsinghua University(清华大学);Central South University(中南大学);University of Glasgow(格拉斯哥大学);China Mobile System Integration Co., Ltd.(中移系统集成有限公司);Subtle Medical Inc.(Subtle Medical公司);University Hospital, LMU Munich(慕尼黑大学医院);Munich Center for Machine Learning(慕尼黑机器学习中心);BC Cancer Research Institute(不列颠哥伦比亚癌症研究所);HES-SO Valais-Wallis University of Applied Sciences and Arts(HES-SO瓦莱州应用科学与艺术大学);Lausanne University Hospital (CHUV)(洛桑大学医院);LaTIM, INSERM, UMR 1101, Univ Brest(LaTIM实验室、法国国家健康与医学研究院、UMR 1101、布雷斯特大学)
Numan Saeed, Salma Hassan, Shahad Hardan, Lishan Cai, Xinglong Liang, Moona Mazher, Abdul Qayyum, Yansong Bu, Mengye Lyu, Yue Lin, Mingyuan Meng, Chuanyi Huang,… 展开作者

Numan Saeed, Salma Hassan, Shahad Hardan, Lishan Cai, Xinglong Liang, Moona Mazher, Abdul Qayyum, Yansong Bu, Mengye Lyu, Yue Lin, Mingyuan Meng, Chuanyi Huang, Lisheng Wang, Dalal Chamseddine, Shamimeh Ahrari, Beining Wu, Yifei Chen, Fuyou Mao, Hao Zhang, Baixiang Zhao, Surajit Ray, Muzi Guo, Lei Xiang, Jakob Dexl, Michael Ingrisch, Adrien Depeursinge, Arman Rahmim, Mathieu Hatt, Vincent Andrearczyk, Mohammad Yaqub

AI总结:

HECKTOR 2025 挑战赛利用多模态 PET/CT 和电子健康记录,建立了头颈癌自动分析的基准,涵盖肿瘤分割、复发预测和 HPV 分类三个任务,最佳算法分别达到 Dice 0.75、C-index 0.66 和平衡准确率 0.56。

摘要:

头颈癌 (HNC) 构成显著的全球健康负担,准确的肿瘤勾画对于有效的放疗计划至关重要。口咽部解剖结构的复杂性,加上肿瘤在影像上的异质性表现,使得手动分割耗时且存在观察者间差异。除分割外,从非侵入性影像预测长期临床结局(如无复发生存期 RFS)和确定人乳头瘤病毒 (HPV) 状态,仍然是具有挑战性但临床价值高的目标。HECKTOR 2025 挑战赛通过使用多模态 PET/CT 影像和电子健康记录,建立了一个用于自动 HNC 分析的全面基准。基于前几届(2020-2022),本次挑战赛采用了扩展的多机构数据集,包含来自全球 10 个中心的 1100 多名患者。参与者需完成三个互补目标:(1) 分割原发肿瘤体积 (GTVp) 和转移淋巴结 (GTVn),(2) 预测无复发生存期,(3) 分类 HPV 状态。挑战赛吸引了 35 个注册团队,其中 15 个最终提交在保留测试集上进行了评估。表现最佳的算法在分割上达到平均 Dice 相似系数 0.75,在生存预测上达到一致性指数 0.66,在 HPV 分类上达到平衡准确率 0.56。本文对所提交的方法进行了全面分析,评估了它们在不同病变特征上的性能,并讨论了它们在自动化肿瘤学工作流程和决策支持系统中临床转化的意义。

英文摘要:

Head and neck cancers (HNC) represent a significant global health burden, with accurate tumor delineation being essential for effective radiotherapy planning. The complexity of the oropharyngeal anatomy, combined with the heterogeneous appearance of tumors on imaging, makes manual segmentation time-intensive and subject to inter-observer variability. Beyond segmentation, predicting long-term clinical outcomes, such as recurrence-free survival (RFS), and determining human papillomavirus (HPV) status from noninvasive imaging, remain challenging yet clinically valuable goals. The HECKTOR 2025 challenge addresses these needs by establishing a comprehensive benchmark for automated HNC analysis using multimodal PET/CT imaging and electronic health records. Building on previous editions (2020-2022), this challenge features an expanded multi-institutional dataset comprising over 1,100 patients from 10 centers worldwide. Participants were tasked with three complementary objectives: (1) segmenting primary gross tumor volumes (GTVp) and metastatic lymph nodes (GTVn), (2) predicting recurrence-free survival, and (3) classifying HPV status. The challenge attracted 35 registered teams, with 15 final submissions evaluated on a held-out test set. Top-performing algorithms achieved a mean Dice similarity coefficient of 0.75 for segmentation, a concordance index of 0.66 for survival prediction, and a balanced accuracy of 0.56 for HPV classification. This paper presents a comprehensive analysis of the submitted methodologies, evaluates their performance across different lesion characteristics, and discusses their implications for clinical translation in automated oncology workflows and decision support systems.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑